Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2019 Filed Jul 3, 2019 14:36 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,844 | $34.64 | $98,507.34 |
DisclosureSEC source: 0001562180-19-003853 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,174,050 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 661 RSUs and 6,250 RSUs, respectively. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.50 to $34.8384. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 215,266 restricted stock units. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 14:36 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 301 | $34.64 | $10,425.71 |
DisclosureSEC source: 0001562180-19-003853 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176,894 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 661 RSUs and 6,250 RSUs, respectively. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.50 to $34.8384. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 18:36 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 49 | $34.64 | $1,697.21 |
DisclosureSEC source: 0001562180-19-003854 · primarydocument.xml · nonDerivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,929 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 208 RSUs and 160 RSUs, respectively, and were effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.50 to $34.8384. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 19,128 restricted stock units. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 18:36 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 63 | $34.64 | $2,182.12 |
DisclosureSEC source: 0001562180-19-003854 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,978 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 208 RSUs and 160 RSUs, respectively, and were effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.50 to $34.8384. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 18:36 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 45 | $34.64 | $1,558.66 |
DisclosureSEC source: 0001562180-19-003855 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,146 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 148 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.50 to $34.8384. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 12,281 restricted stock units. Read SEC document |
| June 17, 2019 Filed Jun 17, 2019 20:30 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,667 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-003550 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,943 Underlying: Common Stock · 1,667 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option is fully vested. Read SEC document |
| June 17, 2019 Filed Jun 17, 2019 20:30 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $32.74 | $54,572.25 |
DisclosureSEC source: 0001562180-19-003550 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,760 F1 · price: This transaction was executed in multiple trades at prices ranging from $32.54 to $33.03. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 9,633 restricted stock units. Read SEC document |
| June 17, 2019 Filed Jun 17, 2019 20:30 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionCommon Stock | 1,667 | $1.93 | $3,217.31 |
DisclosureSEC source: 0001562180-19-003550 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 17:21 UTC |
Fry John JGeneral Counsel & Secretary
|
GrantStock Option (right to buy) · Derivative | 51,177 | $0.00 Strike: $33.48 | $0.00 |
DisclosureSEC source: 0001104659-19-035975 · a4.xml · derivative · entry 2 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,177 Underlying: Common Stock · 51,177 shares Expires 2029-06-14 F2 · derivative.exercise_date: The option vests as to 25% of the shares on June 10, 2020 and vests as to an additional 2.083% of the shares per month at the end of each month for 36 months thereafter beginning June 30, 2020. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 17:21 UTC |
Fry John JGeneral Counsel & Secretary
|
GrantCommon Stock | 22,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-035975 · a4.xml · nonDerivative · entry 1 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,502 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on June 10, 2020 and vest as to an additional 2.083% of the shares per month at the end of each month for 36 months thereafter beginning June 30, 2020. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 16:42 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,870 | $26.01 | $74,646.69 |
DisclosureSEC source: 0001562180-19-003344 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,177,195 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 661 RSUs and 6,250 RSUs, respectively. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.05. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 222,177 restricted stock units. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 16:42 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 203 | $25.81 | $5,239.43 |
DisclosureSEC source: 0001562180-19-003344 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,180,065 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 661 RSUs and 6,250 RSUs, respectively. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:42 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 49 | $25.81 | $1,264.69 |
DisclosureSEC source: 0001562180-19-003343 · primarydocument.xml · nonDerivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,041 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 208 RSUs and 160 RSUs, respectively, and were effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2018. F2 · balance_after: Includes 19,496 restricted stock units. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:42 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 64 | $25.81 | $1,651.84 |
DisclosureSEC source: 0001562180-19-003343 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,090 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 208 RSUs and 160 RSUs, respectively, and were effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2018. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:42 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 46 | $25.81 | $1,187.26 |
DisclosureSEC source: 0001562180-19-003342 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,191 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 148 RSUs. F2 · balance_after: Includes 12,429 restricted stock units. Read SEC document |
| May 15, 2019 Filed May 15, 2019 21:21 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 234 | $21.20 | $4,960.80 |
DisclosureSEC source: 0001562180-19-002823 · primarydocument.xml · nonDerivative · entry 4 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,760 F4 · balance_after: Includes 9,747 restricted stock units. Read SEC document |
| May 13, 2019 Filed May 14, 2019 20:11 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 605 | $20.02 | $12,113.43 |
DisclosureSEC source: 0001562180-19-002796 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,237 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 1,782 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.51 to $20.1316. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 12,577 restricted stock units. Read SEC document |
| May 13, 2019 Filed May 14, 2019 20:11 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 652 | $20.02 | $13,054.47 |
DisclosureSEC source: 0001562180-19-002795 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,154 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 1,920 RSUs and was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.51 to $20.1316. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 19,864 restricted stock units. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:21 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 592 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-002823 · primarydocument.xml · derivative · entry 5 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,610 Underlying: Common Stock · 592 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option is fully vested. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:21 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 451 | $20.02 | $9,030.01 |
DisclosureSEC source: 0001562180-19-002823 · primarydocument.xml · nonDerivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,994 F2 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 1,371 RSUs. F3 · price: This transaction was executed in multiple trades at prices ranging from $19.51 to $20.1316. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:21 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 592 | $21.19 | $12,542.88 |
DisclosureSEC source: 0001562180-19-002823 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,445 F1 · price: This transaction was executed in multiple trades at prices ranging from $21.1538 to $21.22. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:21 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionCommon Stock | 592 | $1.93 | $1,142.56 |
DisclosureSEC source: 0001562180-19-002823 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2019 Filed May 2, 2019 16:21 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,142 | $22.59 | $48,393.14 |
DisclosureSEC source: 0001562180-19-002479 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,180,268 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 6,911 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.40 to $22.7812. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 229,088 restricted stock units. Read SEC document |
| May 01, 2019 Filed May 2, 2019 20:21 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 65 | $22.59 | $1,468.51 |
DisclosureSEC source: 0001562180-19-002480 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,806 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 208 RSUs and was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.7812 to $22.40. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 21,784 restricted stock units. Read SEC document |
| April 12, 2019 Filed Apr 15, 2019 21:00 UTC |
Chaubal AmolChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 62,270 | $0.00 Strike: $22.70 | $0.00 |
DisclosureSEC source: 0001562180-19-002283 · primarydocument.xml · derivative · entry 2 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,270 Underlying: Common Stock · 62,270 shares Expires 2029-04-12 F2 · derivative.exercise_date: The option vests as to 25% of the shares on April 12, 2020 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. In addition if the Company undergoes a change of control within the first 18 months, 50% of the unvested options will vest. Read SEC document |
| April 12, 2019 Filed Apr 15, 2019 21:00 UTC |
Chaubal AmolChief Financial Officer
|
GrantCommon Stock | 18,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-002283 · primarydocument.xml · nonDerivative · entry 1 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,259 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on April 12, 2020 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| April 03, 2019 Filed Apr 3, 2019 16:33 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 200 | $23.42 | $4,683.00 |
DisclosureSEC source: 0001562180-19-002188 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,182,410 F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on June 14, 2018. F4 · price: This transaction was executed in multiple trades at prices ranging from $23.41 to $23.42. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 235,999 restricted stock units. Read SEC document |
| April 03, 2019 Filed Apr 3, 2019 16:33 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 3,800 | $24.69 | $93,815.92 |
DisclosureSEC source: 0001562180-19-002188 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,182,610 F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on June 14, 2018. F3 · price: This transaction was executed in multiple trades at prices ranging from $24.13 to $25.08. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 02, 2019 Filed Apr 3, 2019 16:33 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,817 | $23.27 | $65,551.59 |
DisclosureSEC source: 0001562180-19-002188 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,186,410 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 8,233 RSUs. Read SEC document |
| April 02, 2019 Filed Apr 3, 2019 20:33 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 72 | $23.27 | $1,675.44 |
DisclosureSEC source: 0001562180-19-002189 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,871 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 208 RSUs and was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2018. F2 · balance_after: Includes 21,992 restricted stock units. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:33 UTC |
MEISTER PAUL MDirector
|
GrantCommon Stock | 587 | $23.40 | $13,735.80 |
DisclosureSEC source: 0001562180-19-002187 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,127 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2019, pursuant to an election made in December 2018. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2019. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:33 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 721 | $23.40 | $16,871.40 |
DisclosureSEC source: 0001562180-19-002186 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,261 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2019, pursuant to an election made in December 2018. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2019. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 22:12 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantCommon Stock | 502 | $23.40 | $11,746.80 |
DisclosureSEC source: 0001562180-19-002202 · primarydocument.xml · nonDerivative · entry 1 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,042 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2019, pursuant to an election made in December 2018. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2019. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| March 17, 2019 Filed Mar 19, 2019 20:10 UTC |
Streeter JacksonSVP, Corp Dev & Strategy
|
GrantStock Option (right to buy) · Derivative | 13,889 | $0.00 Strike: $24.87 | $0.00 |
DisclosureSEC source: 0001562180-19-001967 · primarydocument.xml · derivative · entry 2 Streeter Jackson · CIK 0001758379 · SVP, Corp Dev & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,889 Underlying: Common Stock · 13,889 shares Expires 2029-03-17 F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 17, 2020 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| March 17, 2019 Filed Mar 19, 2019 20:10 UTC |
Streeter JacksonSVP, Corp Dev & Strategy
|
GrantCommon Stock | 4,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-001967 · primarydocument.xml · nonDerivative · entry 1 Streeter Jackson · CIK 0001758379 · SVP, Corp Dev & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,515 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on March 17, 2020 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Includes 32,515 restricted stock units. Read SEC document |
| March 17, 2019 Filed Mar 19, 2019 20:10 UTC |
Duffy David C.SVP R&D and CTO
|
GrantStock Option (right to buy) · Derivative | 19,204 | $0.00 Strike: $24.87 | $0.00 |
DisclosureSEC source: 0001562180-19-001968 · primarydocument.xml · derivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,204 Underlying: Common Stock · 19,204 shares Expires 2029-03-17 F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 17, 2020 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| March 17, 2019 Filed Mar 19, 2019 20:10 UTC |
Duffy David C.SVP R&D and CTO
|
GrantCommon Stock | 5,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-001968 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,445 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on March 17, 2020 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Includes 11,118 restricted stock units. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 21:22 UTC |
Roskey Mark T.SVP and GM Apps and Reagents
|
GrantStock Option (right to buy) · Derivative | 24,640 | $0.00 Strike: $22.69 | $0.00 |
DisclosureSEC source: 0001562180-19-001916 · primarydocument.xml · derivative · entry 2 Roskey Mark T. · CIK 0001724565 · SVP and GM Apps and Reagents 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,640 Underlying: Common Stock · 24,640 shares Expires 2029-03-12 F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 12, 2020 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 21:22 UTC |
Roskey Mark T.SVP and GM Apps and Reagents
|
GrantCommon Stock | 7,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-001916 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP and GM Apps and Reagents 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,359 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on March 12, 2020 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Includes 14,359 restricted stock units. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 21:22 UTC |
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
|
GrantStock Option (right to buy) · Derivative | 24,640 | $0.00 Strike: $22.69 | $0.00 |
DisclosureSEC source: 0001562180-19-001915 · primarydocument.xml · derivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,640 Underlying: Common Stock · 24,640 shares Expires 2029-03-12 F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 12, 2020 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 21:22 UTC |
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
|
GrantCommon Stock | 7,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-001915 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,943 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on March 12, 2020 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Includes 22,200 restricted stock units. Read SEC document |
| March 12, 2019 Filed Mar 18, 2019 17:13 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
GrantStock Option (right to buy) · Derivative | 108,177 | $0.00 Strike: $22.69 | $0.00 |
DisclosureSEC source: 0001562180-19-001946 · primarydocument.xml · derivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,177 Underlying: Common Stock · 108,177 shares Expires 2029-03-12 F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 12, 2020 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| March 12, 2019 Filed Mar 18, 2019 17:13 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
GrantCommon Stock | 31,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-001946 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,189,227 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 1,983 of the shares on March 31, 2019 and vest as to an additional 661 shares at the end of each month thereafter for 44 months and as to 665 shares at the end of the 45th month thereafter. F2 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 244,232 restricted stock units. Read SEC document |
| March 01, 2019 Filed Mar 1, 2019 16:57 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,903 | $25.00 | $47,583.18 |
DisclosureSEC source: 0001562180-19-001531 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,157,495 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 6,250 RSUs and was effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.85 to $25.0738. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 212,500 restricted stock units. Read SEC document |
| March 01, 2019 Filed Mar 1, 2019 22:02 UTC |
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
|
SaleCommon Stock | 75 | $25.00 | $1,875.32 |
DisclosureSEC source: 0001562180-19-001532 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,715 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 208 RSUs and was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.85 to $25.0738. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 14,972 shares of restricted stock units. Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 21:10 UTC |
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
|
SaleCommon Stock | 890 | $23.72 | $21,113.92 |
DisclosureSEC source: 0001562180-19-001459 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,790 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 2,500 RSUs and was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $23.56 to $23.751. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 15,180 shares of restricted stock units. Read SEC document |
| February 01, 2019 Filed Feb 1, 2019 18:10 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,952 | $20.90 | $40,795.63 |
DisclosureSEC source: 0001562180-19-000676 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,159,398 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 6,250 RSUs and was effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.87 to $21.02. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 218,750 restricted stock units. Read SEC document |
| January 15, 2019 Filed Jan 15, 2019 16:02 UTC |
DRISCOLL JOSEPHChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $8.68 | $0.00 |
DisclosureSEC source: 0001562180-19-000307 · primarydocument.xml · derivative · entry 5 DRISCOLL JOSEPH · CIK 0001392297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,385 Underlying: Common Stock · 15,000 shares Expires 2027-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option to purchase 301,722 shares of common stock vested as to 25% of the shares on April 24, 2018 and vests as to an additional 2.083% of the shares per month thereafter until March 31, 2021. Read SEC document |
| January 15, 2019 Filed Jan 15, 2019 16:02 UTC |
DRISCOLL JOSEPHChief Financial Officer
|
SaleCommon Stock | 351 | $21.69 | $7,613.68 |
DisclosureSEC source: 0001562180-19-000307 · primarydocument.xml · nonDerivative · entry 4 DRISCOLL JOSEPH · CIK 0001392297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,388 F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2018. F5 · price: This transaction was executed in multiple trades at prices ranging from $21.68 USD to $21.70. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 4,388 shares of common stock issuable upon vesting of restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| January 15, 2019 Filed Jan 15, 2019 16:02 UTC |
DRISCOLL JOSEPHChief Financial Officer
|
SaleCommon Stock | 7,831 | $20.93 | $163,934.15 |
DisclosureSEC source: 0001562180-19-000307 · primarydocument.xml · nonDerivative · entry 3 DRISCOLL JOSEPH · CIK 0001392297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,739 F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2018. F4 · price: This transaction was executed in multiple trades at prices ranging from $20.57 USD to $21.49. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 4,388 shares of common stock issuable upon vesting of restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.